Similarly, the ACE2 immunostaining score was significantly lower in the stage B HF group when compared to the control group (p < 0.001), but no significant difference was observed when comparing the stage B HF group to the stage A HF group. The gene discussed is ACE2; the disease is hydrops fetalis.